580 results on '"Hashim U. Ahmed"'
Search Results
502. Urachal tumour: clinical and radiological features of a poorly understood carcinoma
503. NANOTECHNOLOGY: POTENTIAL APPLICATIONS IN UROLOGY
504. 585 Focal therapy targeted to the index lesion in multifocal prostate cancer: A prospective development study
505. 584 Early clinical experience of focal therapy for localised prostate cancer using irreversible electroporation
506. Efficacy of Electromyography Biofeedback Training on Trunk Stability in Chronic Low Back Pain
507. Efficacy of Muscle Energy Technique in Combination with Strain-counterstrain Technique on Deactivation of Trigger Point Pain
508. Acute Abdomen from a Meckel Lipoma
509. General application of the National Institute for Health and Clinical Excellence (NICE) guidance for active surveillance for men with prostate cancer is not appropriate in unscreened populations
510. Focal HIFU for prostate cancer – Authors' reply
511. The Role of mp-MRI in the Detection of Prostate Cancer
512. 1096 The natural history of untreated prostate MRI lesions in an active surveillance prostate cancer population – 260 patient-years
513. 20 Evolution of the pathological outcomes after radical prostatectomy with increasing use of active surveillance in the UK: Implication for focal therapy
514. 795 What burden of prostate cancer can radiologists rule-out on multi-parametric MRI? An analysis based on template prostate mapping biopsies as the reference standard
515. 824 Multi-parametric magnetic resonance imaging in the diagnosis and characterization of prostate cancer prior to first biopsy in men at risk: The PROMIS study
516. 22 Patterns of prostate cancer on template prostate mapping biopsies in 291 men: Implications for focal therapy
517. 24 MR-directed selective HIFU therapy of prostate cancer using a TRUS guidance platform
518. UP-02.153 An International Multi-Centre Phase II Prospective Trial Evaluating Focal Therapy Using High Intensity Focused Ultrasound (Sonablate 500) for Localized Prostate Cancer
519. MP-03.10 Can Pre-biopsy Multi-parametric MRI Reduce the Number of TRUS Cores Required to Diagnose Prostate Cancer in an 'At-Risk' Population of Men?
520. MP-03.05 Can Pre-Biopsy Multiparametric MRI Be Used to Detect Significant Prostate Cancer?
521. UP-02.164 Impact of Increasing Active Surveillance on Pathological Outcome After Radical Prostatectomy
522. Time to Rethink PSA Screening
523. 528 RE-CLASSIFICATION STRATEGIES IN MEN WITH LOW RISK PROSTATE CANCER: TRUS GUIDED BIOPSY VERSUS TEMPLATE PROSTATE MAPPING
524. 962 RELATIONSHIP OF RADICAL PROSTATECTOMY MARGIN STATUS AND INDEX LESION: IMPLICATIONS FOR PREOPERATIVE EVALUATION OF TUMOUR FOCALITY IN PROSTATE CANCER
525. 893 TRIFECTA OUTCOMES AFTER WHOLE-GLAND HIGH INTENSITY FOCUSED ULTRASOUND FOR THE TREATMENT OF LOCALISED PROSTATE CANCER: A REGISTRY-BASED ANALYSIS
526. 104 WHO OPENED THE PROSTATE CANCER PANDORA'S BOX? A HISTORICAL EVALUATION OF THE DIAGNOSTIC PATHWAY IN PROSTATE CANCER
527. SURGICAL MANAGEMENT AFTER ACTIVE SURVEILLANCE FOR LOW-RISK PROSTATE CANCER: PATHOLOGICAL OUTCOMES COMPARED WITH MEN UNDERGOING IMMEDIATE TREATMENT
528. Focal Therapy Using High Intensity Focused Ultrasound for Intermediate and High Risk Prostate Cancer: A Registry-Based Cohort Analysis
529. Performance Characteristics of Prostate Biopsy Strategies in a Simulation: Transrectal Ultrasound (TRUS) versus Template Prostate Mapping (TPB)
530. Active Surveillance: Is There a Need for Better Risk Stratification at the Outset?
531. 108 TEMPLATE TRANSPERINEAL PROSTATE MAPPING BIOPSIES FOR PROSTATE CANCER RISK STRATIFICATION AND CANCER LOCALIZATION
532. 156 MULTI-PARAMETRIC MAGNETIC RESONANCE IMAGING IN RADIO-RECURRENT PROSTATE CANCER
533. 712 MULTI-PARAMETRIC MAGNETIC RESONANCE IMAGING (MP-MRI) AND LOCALISATION OF SIGNIFICANT PROSTATE CANCER: CAN IT BE USED AS A TRIAGE TOOL?
534. Time to evaluate focal therapy
535. Reply to TS Clark: ‘High-intensity-focused ultrasound in the treatment of primary prostate cancer: the first UK series'
536. Reply to S Eggener, M Gonzalgo and O Yossepowitch: ‘High-intensity-focused ultrasound in the treatment of primary prostate cancer: the first UK series'
537. MP-16.13: Vascular-Targeted Photodynamic Therapy Using WST11 in Patients with Localized Prostate Cancer
538. UP-2.160: Treating Unilateral Localised Prostate Cancer with Hemi-Ablation High Intensity Focused Ultrasound (HIFU): Results of a NCRN-Approved Phase II Focal Therapy Clinical Trial
539. UP-2.161: Focal High Intensity Focused Ultrasound (HIFU) Therapy in the Treatment of Localised Prostate Cancer: Early Results of a Phase II Trial
540. Laboratory Skills for Science and Medicine
541. THE ROLE OF TUMOR FOCALITY IN PROSTATE CANCER FOR THE SELECTION OF PATIENTS FOR FOCAL THERAPY
542. ULTRASOUND BASED TISSUE CHARACTERISATION (HISTOSCANNING) IMAGING FOR PROSTATE CANCER: INTERIM RESULTS FROM THE EXPLORATORY PHASE OF A PROSPECTIVE MULTI-CENTRE TRIAL
543. 615 IS THERE A RELATIONSHIP BETWEEN VOLUME OF PROSTATE CANCER TUMOUR FOCI AND GLEASON SCORES?
544. 941 TISSUE CHARACTERISATION (HISTOSCANNING) FOR DETECTION OF PROSTATE CANCER: INTERIM RESULTS FROM THE EXPLORATORY PHASE OF A PROSPECTIVE MULTI-CENTRE TRIAL
545. 855 HIGH INTENSITY FOCUSED ULTRASOUND (HIFU) HEMIABLATION TRIAL IN LOCALISED UNILATERAL PROSTATE CANCER: INTERIM RESULTS
546. 851 SONABLATE® INTERNATIONAL HIFU REGISTRY (SIHR): A TOOL FOR DYNAMIC QUALITY IMPROVEMENT
547. Irreversible tide of technological advancement?
548. TRANSRECTAL HIGH INTENSITY FOCUSED ULTRASOUND IN THE TREATMENT OF LOCALISED PROSTATE CANCER – THE FIRST UK SERIES
549. PROSTATE CANCER RISK STRATIFICATION AND CANCER MAPPING – TEMPLATE TRANSPERINEAL PROSTATE MAPPING BIOPSIES
550. THE ROLE OF TRANSPERINEAL TEMPLATE PROSTATE MAPPING BIOPSIES IN RISK-STRATIFYING MEN WITH LOCALISED PROSTATE CANCER
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.